empagliflozin retains benefits in ‘true’ hfpef patients
Published 2 years ago • 1.3K plays • Length 5:10Download video MP4
Download video MP3
Similar videos
-
6:28
emperor-reduced: empagliflozin benefits in hf patients irrespective of diabetes | milton packer
-
5:20
empagliflozin safe in acute hf, improves ‘clinical benefit’ over time
-
2:07
fda approves empagliflozin use for heart failure despite contrary results of trials
-
13:59
empagliflozin in hfpef: putting emperor-preserved in context
-
0:59
a comparison of sglt2 drugs: empagliflozin vs dapagliflozin
-
11:43
the truth about jardiance for weight loss: does jardiance help lose weight | dr. dan obesity expert
-
13:16
dapagliflozin - mechanism, side effects, precautions & uses
-
7:22
diabetes medications - sglt 2 inhibitors - empagliflozin (jardiance)
-
6:41
emperor preserved trial. empagliflozin in hfpef patients.
-
8:15
sglt2 inhibitors and heart failure
-
2:38
aha 2021: emperor-preserved: empagliflozin, health status, & qol in patients with hfpef | dr butler
-
13:17
empagliflozin in heart failure with a preserved ejection fraction
-
4:13
journal club - empagliflozin improves heart failure symptoms
-
3:35
hf 2022: deliver extends benefits of dapagliflozin to the full spectrum of pts with hf
-
0:55
further research studies of dapagliflozin
-
34:19
role of sglt2 inhibitor, empagliflozin in the glycaemic control in diabetes
-
0:51
beware of this side effect of empagliflozin
-
1:33
emperor preserved: empagliflozin in heart failure with preserved ejection fraction
-
2:17
aha 2021: empatropism fe: effects of empagliflozin on iron metabolism in non-diabetic hf patients
-
11:36
dr marc pfeffer - hfpef: looking back - forging forward - full version
-
4:57
benefits of empagliflozin persist in reduced renal function: abcd nationwide empagliflozin audit
-
10:31
jardiance for heart failure and diabetes: an in-depth summary